# Effectiveness And Safety Of Dalteparin In Patients With Acute Coronary Syndromes Without ST Elevations In Clinical Practice

> **NCT00922766** · — · COMPLETED · sponsor: **Pfizer** · enrollment: 618 (actual)

## Conditions studied

- Acute Coronary Syndrome

## Interventions

- **DRUG:** Dalteparin

## Key facts

- **NCT ID:** NCT00922766
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2010-09
- **Final completion:** 2010-09
- **Target enrollment:** 618 (ACTUAL)
- **Last updated:** 2012-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00922766

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00922766, "Effectiveness And Safety Of Dalteparin In Patients With Acute Coronary Syndromes Without ST Elevations In Clinical Practice". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00922766. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*